Serious adverse events · people with chronic liver diseases
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Liver morbidity · people with chronic liver diseases
1 finding from 1 review
Health‐related quality of life · people with chronic liver diseases
1 finding from 1 review
Non‐serious adverse events · people with chronic liver diseases
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Failure of sustained virological response · people with chronic liver diseases
It is very uncertain whether vitamin D changes failure of sustained virological response compared with placebo or no intervention (very low certainty).
1 finding from 1 review
All‐cause mortality at last · people with liver metastases
It is very uncertain whether percutaneous ethanol injection changes mortality at last compared with no intervention, other ablation methods, or systemic treatment (very low certainty).
1 finding from 1 review
Time to mortality · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Failure to clear liver metastases or recurrence of liver metastases · people with liver metastases
It is very uncertain whether percutaneous ethanol injection changes failure to clear liver metastases or recurrence of liver metastases compared with no intervention, other ablation methods, or systemic treatment (very low certainty).
1 finding from 1 review
Time to progression of liver metastases · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tumour response measures · people with liver metastases
1 finding from 1 review
Serious adverse events and complications · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with ≥ 1 serious adverse events · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hepatitis B‐related mortality · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hepatitis B‐related morbidity · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐serious adverse events Maximum · chronic hepatitis B
It is very uncertain whether xiao Chai Hu Tang formula changes proportion of participants with ≥ 1 adverse events considered 'not… compared with no intervention (very low certainty).
1 finding from 1 review
Proportion of participants with detectable HBV‐DNA in serum or plasma (at maximum · chronic hepatitis B
It is very uncertain whether xiao Chai Hu Tang formula changes proportion of participants with detectable HBV‐DNA in serum or… compared with no intervention (very low certainty).
1 finding from 1 review
Exploratory outcome: Proportion of participants with detectable HBeAg (at maximum · chronic hepatitis B
It is very uncertain whether xiao Chai Hu Tang formula changes proportion of participants with detectable HBeAg in serum or plasma… compared with no intervention (very low certainty).
1 finding from 1 review